Table 4. Multivariate analysis of... | American Society of Hematology

Table 4.

Multivariate analysis of factors influencing AUC for T-cell recovery at 4 and 6 months

	P values
	CD3			CD8			CD4
	AUC to 4 mo	AUC to 6 mo	AUC to 4 mo	AUC to 6 mo	AUC to 4 mo	AUC to 6 mo
Dose level 1 vs 2	.002*	.043*	.005*	.036*	.012*	.136
Malignant vs nonmalignant	.311	.569	.185	.249	.771	.821
Conventional-intensity vs nonmyeloablative conditioning	.734	.742	.597	.695	.769	.6
Post-SCT immunosuppression vs none	.497	.528	.509	.409	.821	.774

	P values
	CD3			CD8			CD4
	AUC to 4 mo	AUC to 6 mo	AUC to 4 mo	AUC to 6 mo	AUC to 4 mo	AUC to 6 mo
Dose level 1 vs 2	.002*	.043*	.005*	.036*	.012*	.136
Malignant vs nonmalignant	.311	.569	.185	.249	.771	.821
Conventional-intensity vs nonmyeloablative conditioning	.734	.742	.597	.695	.769	.6
Post-SCT immunosuppression vs none	.497	.528	.509	.409	.821	.774

Statistically significant.